Deutsche Post: With the acquisition of Cryopdp, the logistics provider accelerates its expansion in the healthcare and life sciences sector!
Reading Time: 3 minutes
With the acquisition, Deutsche Post is taking a significant step closer to its goal of becoming one of the leading companies in health and life sciences logistics. Deutsche Post and Cryoport, the parent company of Cryopdp, also announced a strategic partnership aimed at optimizing both companies' supply chain service offerings for global life sciences and healthcare. In 2024, Deutsche Post generated a revenue of 5 billion euros globally in the life sciences and healthcare (LSHC) business. Cryopdp, which operates in 15 countries and delivers 600,000...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
